Detected ·

Nouscom

€120MSeries D

Nouscom announced an oversubscribed €120M ($135M) Series D financing, co-led by M Ventures and Revelation Partners, to advance NOUS-209 into a pivotal trial for cancer interception in Lynch syndrome.

Website
—
Amount
€120 000 000 EUR
Stage
Series D
Event
Funding round
Detected
2026-10-20 08:06:12 UTC
Signal ID
fcedf948-4b71-45cb-9653-ec292195ad87

As the API returns it

{
  "id": "fcedf948-4b71-45cb-9653-ec292195ad87",
  "created_at": "2026-10-20T08:06:12.642268Z",
  "company_name": "Nouscom",
  "company_website_url": null,
  "company_linkedin_url": "https://www.linkedin.com/company/18328527",
  "event_type": "funding",
  "funding_amount": 120000000,
  "funding_currency": "EUR",
  "funding_stage": "series_d",
  "message": "*Nouscom announced an oversubscribed €120M ($135M) Series D financing, co-led by M Ventures and Revelation Partners, to advance NOUS-209 into a pivotal trial for cancer interception in Lynch syndrome.*"
}

Latest rounds